Perimenopausal Depression: Why Hormones Deserve a First Look
When a woman in her late 30s, 40s, or early 50s walks into an office feeling low, flat, anxious, or unlike herself, the reflex is familiar. Write a prescription for an antidepressant. Move on.
This has become standard care. But standard does not always mean correct.
Perimenopause is a hormonal transition, not just a life phase. And when mood changes begin during this window, the first question should not be which antidepressant to use. It should be why the mood has changed at all.
Research consistently shows that women are at higher risk for new depression or relapse during the menopausal transition.
Why Mood Shifts Are So Common in Perimenopause
Perimenopause is often described as irregular periods and hot flashes. That description barely scratches the surface.
During this stage, estrogen, progesterone, and testosterone fluctuate sharply and then slowly decline. These hormones do not just act on the ovaries. They act on the brain. Estrogen, in particular, plays a direct role in serotonin, dopamine, and GABA signaling, the same systems targeted by antidepressants.
When estrogen levels become unpredictable, brain signaling becomes less stable. Sleep suffers. Focus drops. Anxiety rises. Mood follows.
Research consistently shows that women are at higher risk for new depression or relapse during the menopausal transition. This is not coincidence. It is physiology.
How We Got Here
In the early 2000s, hormone therapy prescriptions dropped dramatically after the release of the Women’s Health Initiative data. What filled the gap was not better education or nuance. It was a surge in antidepressants, sleep medications, and anxiety drugs.
Over time, prescribing SSRIs became the default response to midlife mood symptoms, even when those symptoms appeared alongside hot flashes, night sweats, brain fog, low libido, and fatigue.
The problem is that SSRIs treat neurotransmitters while ignoring the hormonal trigger driving the disruption.
What the Evidence Now Shows
Antidepressants can help some women. They are not useless. But their effect on menopause-related mood symptoms is modest, and the data supporting them in this setting is limited.
In contrast, estrogen has well-documented effects on brain health. Studies of women treated with body-identical estradiol, often paired with progesterone and sometimes testosterone, show meaningful improvement in mood, energy, focus, anxiety, and sexual health. These benefits are seen even in women who were already taking antidepressants.
New imaging research adds another important piece. During the menopause transition, estrogen receptors increase in key brain regions that regulate mood and memory. This appears to be the brain responding to falling hormone levels. In simple terms, the brain is asking for estrogen.
Blood tests may look normal. Age may not tell the story. But symptoms do.
Why Earlier Research Missed the Mark
Much of the older hormone therapy research that shaped fear and hesitation used outdated hormone formulations, very low doses, or included women far past menopause who were not struggling with mood symptoms.
Many participants had no depression to treat in the first place.
Modern hormone therapy is different. Body-identical hormones, individualized dosing, and transdermal delivery have changed both safety and outcomes. Yet clinical habits have been slow to catch up.
Where SSRIs Fit and Where They Do Not
SSRIs absolutely have a role. Women with long-standing major depression, severe anxiety disorders, or those who cannot or do not want to use hormones may benefit greatly from them.
But when depression is new, begins during perimenopause, and appears alongside other hormone-related symptoms, reaching first for an antidepressant can delay real relief.
SSRIs also carry side effects that matter to women in midlife, including sexual dysfunction, emotional flattening, weight gain, bone risk, and difficult withdrawal for some patients.
Hormone therapy, when appropriate, often addresses the root cause with fewer long-term tradeoffs.
A More Thoughtful First Step
When I evaluate a woman with new or worsening depression in perimenopause, I look for patterns.
Is she still menstruating or within a year of her last cycle?
Did mood changes begin during this transition?
Are there signs like poor sleep, brain fog, low libido, or fatigue?
If the answer is yes, hormone therapy with body-identical estradiol and progesterone is often the first step. Dosing is personalized. Delivery is chosen carefully. Mental health history is always part of the decision. Psychiatry is involved when needed.
This is not an either-or choice. It is about sequence and cause.
The Takeaway
Perimenopausal depression is not the same as depression at other stages of life. It is often hormonally driven, and it is often treatable by addressing that shift directly.
For many women, hormone therapy should be considered first, not last.
We owe women better questions, better education, and better care. Treating symptoms without addressing their source is not thoughtful medicine.
Midlife mood changes are not a personal failure. They are a signal. And when we listen to that signal, outcomes improve.
Defy Menopause - Own the Change
Many women tell me: "One day I feel amazing. The next, I can barely get out of bed. Is this normal?"
Yes, it is. And no, you don’t have to suffer through it alone.
Hormonal fluctuations during perimenopause can make you feel like you’ve lost control of your body. But knowledge is powerful. And there are clear, science-backed ways to support your hormones, ease symptoms, and reclaim your energy.
That’s exactly why I created Defy Menopause: Own the Change — a 30-day program designed to give you the tools, knowledge, and support you need to move through these changes with clarity and confidence.
Inside, you’ll find:
Weekly access to Dr. Tracy Verrico at live, group sessions
Clear action steps for managing symptoms naturally
Because you deserve more than just "putting up with it."
You deserve to thrive.
Let’s Connect
Schedule an Appointment | LinkedIn | YouTube | Instagram | Bona Dea Gynecology
